Waldencast plc Class A Ordinary Share (WALD) — Analysis Summary
Waldencast plc Class A Ordinary Share (WALD) has a market cap of $174.43M with year-over-year revenue growth of -0.7%. Net margin stands at -84.4%. The stock trades at a P/E ratio of -0.8.
Key Takeaways
- Revenue changed -0.7% year-over-year
- Net margin of -84.4%
- P/E ratio of -0.8
Compared to other companies in the PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS sector, WALD posted revenue growth of -0.7% and trades at a P/E of -0.8.
Waldencast plc Class A Ordinary Share (WALD)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Operating margin at -80.0% — severe operating losses
Net margin at -84.4% — significant losses
The latest filing shows negative free cash flow.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
Sector
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Employees
364
Headquarters
WHITE PLAINS, NY
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.